Literature DB >> 8407971

Function of the hydrophilic carboxyl terminus of type II DNA topoisomerase from Drosophila melanogaster. I. In vitro studies.

D G Crenshaw1, T Hsieh.   

Abstract

The function of the hydrophilic carboxyl-terminal region of Drosophila DNA topoisomerase II was examined by constructing a series of deletion mutants at the 3'-end of the Drosophila Top2 cDNA. The truncated enzymes were then expressed in Saccharomyces cerevisiae. Deletion of up to 240 out of 1447 total amino acids had no apparent effect on the enzyme's ability to catalyze topisomerization reactions. When 273, or more, amino acids were deleted, the enzyme was no longer active. Examples were found where deletion of less than 240 amino acids inactivated the enzyme. Based on the hydrodynamic properties determined for one of these mutants, the lack of activity was most likely due to misfolding of the polypeptides. The active mutants have similar hydrodynamic properties and heat inactivation profiles as the intact enzyme, suggesting that they are dimeric and stably folded. The carboxyl-terminal 240 amino acids also were not required for interaction with the drug VM26. The only difference noted between the shortest, active mutant and the full-length enzyme was a decrease in the stability of the interaction of the truncated enzyme with DNA as evidenced by a decrease in the ionic strength at which catalysis was optimal and at which the transition between a processive and distributive mode of supercoil relaxation occurred.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8407971

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzyme.

Authors:  Jennifer S Dickey; Neil Osheroff
Journal:  Biochemistry       Date:  2005-08-30       Impact factor: 3.162

2.  Topoisomerase II forms multimers in vitro: effects of metals, beta-glycerophosphate, and phosphorylation of its C-terminal domain.

Authors:  Y S Vassetzky; Q Dang; P Benedetti; S M Gasser
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

Review 3.  Structure and function of type II DNA topoisomerases.

Authors:  P M Watt; I D Hickson
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

Review 4.  SUMO modification of DNA topoisomerase II: trying to get a CENse of it all.

Authors:  Ming-Ta Lee; Jeff Bachant
Journal:  DNA Repair (Amst)       Date:  2009-02-20

5.  Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain.

Authors:  A Kathleen McClendon; Amanda C Gentry; Jennifer S Dickey; Marie Brinch; Simon Bendsen; Anni H Andersen; Neil Osheroff
Journal:  Biochemistry       Date:  2008-12-16       Impact factor: 3.162

6.  The C-terminal domain of Saccharomyces cerevisiae DNA topoisomerase II.

Authors:  P R Caron; P Watt; J C Wang
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

7.  The C-terminal 20 Amino Acids of Drosophila Topoisomerase 2 Are Required for Binding to a BRCA1 C Terminus (BRCT) Domain-containing Protein, Mus101, and Fidelity of DNA Segregation.

Authors:  Yu-Tsung Shane Chen; Jianhong Wu; Paul Modrich; Tao-Shih Hsieh
Journal:  J Biol Chem       Date:  2016-04-27       Impact factor: 5.157

8.  Antitumor bisdioxopiperazines inhibit yeast DNA topoisomerase II by trapping the enzyme in the form of a closed protein clamp.

Authors:  J Roca; R Ishida; J M Berger; T Andoh; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

9.  Chiral discrimination and writhe-dependent relaxation mechanism of human topoisomerase IIα.

Authors:  Yeonee Seol; Amanda C Gentry; Neil Osheroff; Keir C Neuman
Journal:  J Biol Chem       Date:  2013-03-18       Impact factor: 5.157

10.  Abundance of nuclear DNA topoisomerase II is correlated with proliferation in Arabidopsis thaliana.

Authors:  S Xie; E Lam
Journal:  Nucleic Acids Res       Date:  1994-12-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.